ArticleThe Journal of urology2011
Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction.
Article in The Journal of urology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 80 citations in OpenAlex.
- CIRSE Standards of Practice on Nephrostomy and Ureteric Stent Placement and Exchange.Cardiovascular and interventional radiology · 2026Guideline
- Comparison of the efficacy and safety of metallic ureteral stent versus polymer ureteral stent for patients with malignant ureteral obstruction: a meta-analysis of comparative trials.World journal of urology · 2026Pooled it
- Article
- Article
- Initial experience of a novel ureteral silicon-covered metallic mesh stent in malignant ureteric obstruction: a single-center retrospective study.BMC urology · 2024Article
- Urinary Diversion Can Improve the Chance of Implementing New Therapeutic Lines in Patients with Malignant Ureteral Obstruction: A Multicenter Study.Current oncology (Toronto, Ont.) · 2024Article
- Malignant upper urinary tract obstruction in cancer patients: A systematic review.BJUI compass · 2024Review
- Management of malignant ureteric obstruction with ureteric stenting or percutaneous nephrostomy.The British journal of surgery · 2024Article
- Can preoperative ureteral stents reduce the incidence of ureteral stricture after radiotherapy in patients with cervical cancer?BMC urology · 2022Article
- Fluoroscopy-guided trans-urethral exchange of double-J ureteral stents.BMC urology · 2022Article
- Evaluation of Galdakao-modified Valdivia position in endoscopic management of malignant ureteric obstruction.International urology and nephrology · 2022Article
- A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study.Scientific reports · 2021Article
- Clinical factors predicting ureteral stent failure in patients with external ureteral compression.Open medicine (Warsaw, Poland) · 2021Article
- Article
- Role of Preoperative Ureteric Stenting in Optimization of Patients with Retroperitoneal Tumors Associated with Obstructive Uropathy.Indian journal of surgical oncology · 2020Article
- Ureteroiliac artery fistula caused by full-length metallic ureteral stenting in a malignant ureteral obstruction: a case report.Journal of medical case reports · 2020Article
- Percutaneous nephrostomy in obstructing pelvic malignancy does not facilitate further oncological treatment.International urology and nephrology · 2020Article
- Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.International journal of clinical oncology · 2019Article
- Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.European radiology · 2019Article
- Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversion.World journal of urology · 2019Review
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe analyzed the prognostic factors associated with overall survival and predictive factors of stent failure in patients treated with an indwelling retrograde ureteral stent for malignant ureteral obstruction. MATERIALS AND
methodsAmong 186 Japanese patients treated with an indwelling retrograde ureteral stent for ureteral obstruction from January 2005 to March 2010, 61 with malignant ureteral obstruction and 95 ureteral units were analyzed retrospectively.
resultsMedian survival was estimated at 228 days. Unfavorable prognostic factors of overall survival were no treatment after indwelling retrograde ureteral stent placement (p = 0.023) and a serum creatinine before indwelling retrograde ureteral stent placement of 1.2 mg/dl or greater (p = 0.016). Overall survival differed significantly among cancer groups (p <0.001) as did stent failure-free survival (p = 0.011). Overall survival differed significantly among 3 risk groups divided according to the score calculated with regard to prognostic factors (p <0.001).
conclusionsGynecologic cancer was a significant favorable predictor of stent failure-free survival. Patients treated with an indwelling retrograde ureteral stent for malignant ureteral obstruction were divided into 3 groups, which showed significant differences in overall survival. This risk classification may help urologists predict survival time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.